scispace - formally typeset
F

F. Chris Minion

Researcher at Iowa State University

Publications -  17
Citations -  1340

F. Chris Minion is an academic researcher from Iowa State University. The author has contributed to research in topics: Mycoplasma hyopneumoniae & Gene. The author has an hindex of 16, co-authored 17 publications receiving 1271 citations.

Papers
More filters
Journal ArticleDOI

The Genome Sequence of Mycoplasma hyopneumoniae Strain 232, the Agent of Swine Mycoplasmosis

TL;DR: The complete genome sequence of Mycoplasma hyopneumoniae, an important member of the porcine respiratory disease complex, is presented, finding few genes with tandem repeat sequences that could be involved in phase switching or antigenic variation and it is not clear how M. hyop pneumoniae evades the immune response and establishes a chronic infection.
Journal ArticleDOI

Proteolytic processing of the Mycoplasma hyopneumoniae cilium adhesin

TL;DR: It is shown that the cilium adhesin is proteolytically processed on the surface, with processing is complex, with cleavage occurring at different frequencies within multiple sites, and is strain specific.
Journal ArticleDOI

Real-Time PCR Assays To Address Genetic Diversity among Strains of Mycoplasma hyopneumoniae

TL;DR: Two new real-time PCR assays that are specific and capable of detecting all of the M. hyopneumoniae isolates used in this study were developed were developed.
Journal ArticleDOI

Use of a Mycoplasma Hyopneumoniae Nested Polymerase Chain Reaction Test to Determine the Optimal Sampling Sites in Swine

TL;DR: The nested PCR developed for this study was found to be a highly sensitive and specific diagnostic tool for M. hyopneumoniae, but the enhanced sensitivity may be unnecessary if the proper sites are sampled.
Journal ArticleDOI

Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.

TL;DR: These studies offer an approach by which a thorough understanding of the mechanisms governing antigenic instability can be elucidated in order to optimize the in vivo performance of biodegradable delivery devices as protein carriers and/or vaccine adjuvants.